Biliary Tract Cancer
📧 Sign up to get email alerts when something new happens for Biliary Tract Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery [NA]
Clinical trial update indicating ongoing recruitment for a study on optimal perioperative pain control in minimally invasive abdominal cance…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: XmAb20717 in Advanced Biliary Tract Cancers [Phase 2]
Phase 2 clinical trial update for XmAb20717 in advanced biliary tract cancers, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer
A CHA University-sponsored clinical trial (NCT06893380) is evaluating the combination of GCNT and tislelizumab in locally advanced or metast…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer [Phase 2]
Phase 2 study evaluating ZW25 (zanidatamab) in combination chemotherapy for HER2-expressing gastrointestinal cancers, including gastroesopha…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer [NA]
This document notes a clinical trial evaluating Yueju Pill in combination with standard therapy for advanced biliary tract cancer, with the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Disitamab Vedotin with Lenvatinib and PD-1 inhibitors for HER2-positive advanced biliary tract cancer…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer [Phase 2]
Phase 2 study evaluating paclitaxel micelle in combination with immunotherapy for biliary tract cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update evaluating trilaciclib for bone marrow protection during chemotherapy in advanced biliary tract cancer and p…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer [NA]
A clinical trial is currently recruiting to evaluate MiniPDX-based postoperative adjuvant therapy for biliary tract cancer.
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial is studying QLS31905 in combination with chemotherapy, with or without QL2107, for CLDN18.2-positive advanced bilia…
-
CLINICAL_TRIALS withdrawal · 2025-09-02Clinical Trial Update: Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures [Phase 2]
Phase 2 trial targeting MDMD and PD-1 in tumors with tertiary lymphoid structures has been withdrawn; the study covered soft tissue sarcoma,…
-
CLINICAL_TRIALS other · 2025-09-02Clinical Trial Update: Use of Ctdna in Patients With Gastrointestinal Tract Tumors
Clinical trial evaluating the use of circulating tumor DNA in gastrointestinal tract tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) [NA]
ClinicalTrials.gov update reports that the PREV-Ex trial evaluating blood flow restriction exercise in patients with pancreatic cancer, bili…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Biomarker Discovery in Patients With Advanced Biliary Tract Cancer
A completed clinical trial update describing biomarker discovery efforts in patients with advanced biliary tract cancer, including cholangio…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Observational Monocentric Study on Biliary Tract Cancer (BABEL)
A monocentric observational study called BABEL focusing on biliary tract cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer [Phase 2]
A Phase 2, single-arm, multicenter exploratory trial is evaluating Adebrelimab plus Apatinib and systemic chemotherapy for initially unresec…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Trastuzumab Rezetecan Combined With Pertuzumab and Iparomlimab and Tuvonralimab for Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial evaluating a quadruple combination therapy (Trastuzumab Rezetecan, Pertuzumab, Iparomlimab, and Tuvonralimab) for b…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. [Phase 2]
A Phase 2 clinical trial evaluating SPH5030 tablets for HER2-positive/mutated biliary tract cancer or colorectal cancer is currently recruit…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers [NA]
Mayo Clinic is recruiting for a study of Acceptance and Commitment Therapy for reducing cancer-related distress in patients with malignant h…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen [Phase 2]
A Phase II clinical study protocol evaluating a second-line liposomal irinotecan combination regimen for advanced biliary tract cancers; cur…
-
CLINICAL_TRIALS withdrawal · 2025-07-24Clinical Trial Update: A Trial of SHR1258 in Patients With Biliary Tract Cancer [Phase 2]
A Phase 2 clinical trial of SHR1258 for biliary tract cancer has been withdrawn by the sponsor.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
The ACABi PRONOBIL study is investigating prognostic and predictive biomarkers of treatment response in patients with biliary tract cancer a…
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. [Phase 2]
Phase 2 clinical trial evaluating durvalumab with tremelimumab, with or without paclitaxel, for advanced biliary tract cancer after platinum…
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: NGS as the First-line Treatment in Advanced Biliary Tract Cancer [Phase 2]
A Phase 2 trial evaluating next-generation sequencing-guided first-line treatment for advanced biliary tract cancer has completed.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line [Phase 2]
Phase 2 clinical trial evaluating mFOLFOX/mFOLFIRI versus mFOLFOX as second-line therapy in advanced or recurrent biliary tract cancer; curr…